Back to search

Article

Initial efficacy determination and resistance profile of anti- <i>Acinetobacter</i> antibiotics, turnercyclamycins

2021-11-03

Abstract excerpt

Drug-resistant Acinetobacter is a challenging, deadly pathogen of increasing prevalence in the US healthcare system. Recently, we described a series of lipopeptides, the turnercyclamycins, which retain potency against Acinetobacter strains that are resistant to the last-line antibiotic, colistin. To further evaluate the potential of turnercyclamycins, we completed mouse efficacy, pharmacokinetics, and toxicity s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
75a58490-8eb3-5904-8a74-b658eabd7288
DOI
10.1101/2021.11.01.466777
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Initial efficacy determination and resistance profile of anti- <i>Acinetobacter</i> antibiotics, turnercyclamycinsDOI 10.1101/2021.11.01.466777
Select a neighboring publication to make it the new centre.